Hypothesis

Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19

Sedokani A, Feizollahzadeh S

Drug Design, Development and Therapy 2020, 14:2607-2611

Published Date: 6 July 2020